Metraipolis › archive › dc_097ccdc643bb

Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United Kingdom — Europe PMC PMID:42774209

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42774209
DOI: 10.3389/fcvm.2026.1858743
License (as archived): solo-consultazione
Archived: 2026-10-15T21:58:50.750Z
SHA-256 of the archived text: 8abbfd1ce07a247dd0a285e1e7db4497acf7e99b41f2ca4150df19a9f2b247a7
Stable URL of this page: https://metraipolis.com/documento/dc_097ccdc643bb

How to cite

Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United Kingdom — Europe PMC PMID:42774209 — Europe PMC (en), https://europepmc.org/article/MED/42774209 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_097ccdc643bb (Metraipolis archive dc_097ccdc643bb, sha256 8abbfd1ce07a247dd0a285e1e7db4497acf7e99b41f2ca4150df19a9f2b247a7)

BibTeX

@misc{dc097ccdc643bb,
  title = {Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United Kingdom — Europe PMC PMID:42774209},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42774209},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_097ccdc643bb; sha256 8abbfd1ce07a247dd0a285e1e7db4497acf7e99b41f2ca4150df19a9f2b247a7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42774209. Agents can read the archived copy with the MCP tool read_document.